CompletedPhase 4

Efficacy and Safety of Different Doses of Vaginal Misoprostol Prior to Intra Uterine Contraceptive Device Insertion

Egypt180 participantsStarted 2020-03-01

Plain-language summary

investigators aim through this study to evaluate and compare the Safety and efficacy of different doses of misoprostol prior to IUCD insertion among women with nulliparous cervix beside the rate of occurrence of adverse effects.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Non-pregnant, * Nulliparous cervix: no previous vaginal delivery or any attempt of vaginal delivery, * Seeking for IUD insertion, * Signing an informed consent to participate in the study, Exclusion Criteria: * Pregnancy or signs of pregnancy, * Signs of cervicitis, * Any uterine abnormalities as congenital anomalies, endometrial lesions, adenomyosis, fibroids and intrauterine adhesions, * Women with any kind of pelvic pain, * Abnormal uterine bleeding, * History of cervical surgery,• Vaginal delivery, * Contraindication to misoprostol as allergy, * Administration of any analgesics last 12h, * Withdrawal of consent

What they're measuring

Pain scores

Timeframe: during insertion of IUCD

Trial details

NCT IDNCT04273984

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-06-15

View on ClinicalTrials.gov More Intra-uterine Device Complication trials